ConductScience.org, home

Paper950320

CGP 9000: a new orally active, broad-spectrum cephalosporin.

Zak O and 8 others. J Antibiot (Tokyo), 1976. Cited by 28 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. CGP 9000: a new orally active, broad-spectrum cephalosporin. Papers, record 950320. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/950320

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CGP 9000: a new orally active, broad-spectrum cephalosporin.
PubMed
Journal
J Antibiot (Tokyo)
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
1.23
iCite
Revised in PubMed
2019-07-23
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zak OO
2Vischer WAW A
3Schenk CC
4Tosch WW
5Zimmermann WW
6Regös JJ
7Suter ERE R
8Kradolfer FF
9Gelzer JJ

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteriaMajor topic
CephalosporinsMajor topic
Animals
Bacterial Infections
Cephalexin
Cephradine
Female
Lethal Dose 50
Mice
Time Factors

Source PubMed

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
7,447,423Pharmacokinetic comparison of cefroxadin (CGP 9000) and cephalexin by simultaneous administration to humans.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7447423PubMed
7,069,577Pharmacokinetics of cefroxadin (CGP 9000) in man.J Pharmacokinet Biopharm1982https://conductscience.org/library/papers/7069577PubMed
6,832,192Elimination of cefroxadine (CGP-9000) from patients undergoing dialysis.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6832192PubMed
6,561,017In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6561017PubMed
6,436,182A randomized double-blind investigation of cefroxadine (CGP 9000) versus cephalexin in urinary tract infection.Infection1984https://conductscience.org/library/papers/6436182PubMed
6,341,252Activity of cefroxadine and cephalexin in urinary tract infections: a double-blind comparative study.Infection1983https://conductscience.org/library/papers/6341252PubMed
3,499,115In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral beta-lactam antibiotics.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3499115PubMed
3,310,868In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3310868PubMed
718,154SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/718154PubMed
533,358Governmental toxicology regulations: an encumbrance to drug research?Arch Toxicol1979https://conductscience.org/library/papers/533358PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/950320

GET https://conductscience.org/api/papers/v1/950320/authors